Metraipolis › archive › dc_c620966d87f6

Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study — Europe PMC PMID:41420258

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41420258
DOI
10.1186/s13195-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-07T12:17:06.047Z
SHA-256 of the archived text
18bc24fb39a30ec4a677464c3dd2ff32d81a6f0c3594c2cb8202c0a56933ee40
Stable URL of this page
https://metraipolis.com/documento/dc_c620966d87f6

How to cite

Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study — Europe PMC PMID:41420258 — Europe PMC (en), https://europepmc.org/article/MED/41420258 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c620966d87f6 (Metraipolis archive dc_c620966d87f6, sha256 18bc24fb39a30ec4a677464c3dd2ff32d81a6f0c3594c2cb8202c0a56933ee40)
BibTeX
@misc{dcc620966d87f6,
  title = {Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study — Europe PMC PMID:41420258},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41420258},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c620966d87f6; sha256 18bc24fb39a30ec4a677464c3dd2ff32d81a6f0c3594c2cb8202c0a56933ee40},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41420258. Agents can read the archived copy with the MCP tool read_document.